Liao Chun-Ta, Huang Shiang-Fu, Chen I-How, Chang Joseph Tung-Chieh, Wang Hung-Ming, Ng Shu-Hang, Hsueh Chuen, Lee Li-Yu, Lin Chih-Hung, Cheng Ann-Joy, Yen Tzu-Chen
Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC.
Ann Surg Oncol. 2009 Jan;16(1):159-70. doi: 10.1245/s10434-008-0196-4. Epub 2008 Nov 15.
Clinical outcome of patients with oral cavity squamous cell carcinoma (OSCC) and contralateral neck recurrence (CLNR) remains poor. We sought to identify factors associated with CLNR and incorporate them into a risk stratification scheme. Between January 1996 and June 2006, a total of 913 consecutive OSCC patients treated by radical surgery were investigated. Postoperative adjuvant therapy was performed in the presence of pathological risk factors. The duration of follow-up was at least 24 months in all surviving patients. Outcome measures were the 5-year CLNR and overall survival rates. In the entire study cohort, the 5-year CLNR rate was 7% (55/913). Specifically, it was 18% (17/132) in patients with local recurrence (LR), and 5% (38/781) in those without (P = 0.0002). In multivariate analysis, extracapsular spread (ECS) was the only independent risk factor for CLNR in patients with LR. Tumor subsite, poor differentiation, and presence of pN + disease were significant predictors of CLNR in patients without LR. We identified two groups of patients with high CLNR rates. The first group consisted of patients with ECS at the initial diagnosis and LR. The second group consisted of subjects with tongue cancer without LR harboring at least two risk factors. We conclude that, in patients who achieved local control, postoperative contralateral neck treatment is recommended for subjects with tongue cancer and at least two risk factors. Once LR occurs, contralateral neck treatment is recommended in patients with ECS.
口腔鳞状细胞癌(OSCC)患者发生对侧颈部复发(CLNR)的临床结局仍然较差。我们试图确定与CLNR相关的因素,并将其纳入风险分层方案。在1996年1月至2006年6月期间,对总共913例接受根治性手术治疗的连续OSCC患者进行了调查。存在病理风险因素时进行术后辅助治疗。所有存活患者的随访时间至少为24个月。结局指标为5年CLNR率和总生存率。在整个研究队列中,5年CLNR率为7%(55/913)。具体而言,局部复发(LR)患者中为18%(17/132),无局部复发患者中为5%(38/781)(P = 0.0002)。在多变量分析中,包膜外扩散(ECS)是LR患者CLNR的唯一独立危险因素。肿瘤亚部位、低分化以及pN+疾病的存在是无LR患者CLNR的重要预测因素。我们确定了两组CLNR率较高的患者。第一组由初诊时存在ECS且发生LR的患者组成。第二组由无LR但患有至少两个危险因素的舌癌患者组成。我们得出结论,在实现局部控制的患者中,对于患有舌癌且至少有两个危险因素的患者,建议进行术后对侧颈部治疗。一旦发生LR,对于存在ECS的患者建议进行对侧颈部治疗。